Evidence map›Paper›PMID 36682773›Full record

ArticleJournal of atherosclerosis and thrombosis2023

Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022.

Mariko Harada-Shiba, Hidenori Arai, Hirotoshi Ohmura, Hiroaki Okazaki, Daisuke Sugiyama, Hayato Tada, Kazushige Dobashi, Kota Matsuki, Tetsuo Minamino, Shizuya Yamashita and 1 more

Abstract readLetter
In one paragraph

Article in Journal of atherosclerosis and thrombosis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Current and Future Perspectives of LDL-C Lowering Therapies 2026.Journal of atherosclerosis and thrombosis · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mariko Harada-ShibaCardiovascular Center, Osaka Medical and Pharmaceutical University.
Hidenori AraiNational Center for Geriatrics and Gerontology.
Hirotoshi OhmuraDepartment of Cardiovascular Biology and Medicine, Juntendo University, School of Medicine.
Hiroaki OkazakiDivision of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University.
Daisuke SugiyamaFaculty of Nursing And Medical Care, Keio University.
Hayato TadaDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine.
Kazushige DobashiDepartment of Pediatrics, School of Medicine, University of Yamanashi.
Kota MatsukiDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine.
Tetsuo MinaminoDepartment of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University.
Shizuya YamashitaDepartment of Cardiology, Rinku General Medical Center.
Koutaro YokoteDepartment of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood Component RemovalHyperlipoproteinemia Type IIAdultCholesterol, LDLHeterozygoteHomozygoteHumansCholesterol, LDLAdultsDiagnostic criteriaFamilial HypercholesterolemiaHeterozygoteHomozygoteLDL apheresisLifestylePharmacological therapyStatinsTreatment guidelines

Identifiers

PMID36682773
PMCPMC10164595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.